Nadroparin calcium
Term · Oncology and biomedicine · MLC-T-ONC-015408
A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.
| Identifier | MLC-T-ONC-015408 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nadroparin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015408",
"term": "Nadroparin calcium",
"field": "Oncology and biomedicine",
"definition": "A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.",
"synonyms": [
"nadroparin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nadroparin-calcium/"
}
Record 11,550 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.